Clinical study of a fixed-dosed mitiglinide/voglibose combination in patients with type 2 diabetes mellitus - Clinical assessment of glycemic markers, HbA1c, glycated albumin and 1,5-anhydroglucitol

Therapeutic Research

Volumn 34, Issue 3, 2013, Pages 379-390

  Hiyoshi, Toru ^a   Shiozaki, Masahide ^b   Inoue, Masahiro ^c   Takahashi, Toshimasa ^d   Nishikawa, Fuminori ^e   Naito, Hirokuni ^f   Nakamura, Joe ^g   Toyoda, Michiaki ^h   Satoh, Yoshihiko ⁱ  

^a JAPANESE RED CROSS MEDICAL CENTER   (Japan)

^b Shiozaki Clinic   (Japan)

^c AIKI Bldg   (Japan)

^d Shinjuku Minamiguchi Ekimae Clinic   (Japan)

^e Hiroo Tower Clinic ^*  (Japan)

^f Naito Hospital   (Japan)

^g Harajuku Clinic   (Japan)

^h Jinai Clinic   (Japan)

ⁱ Satoh Medical Clinic   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1,5 ANHYDROSORBITOL; GLYCOSYLATED ALBUMIN; HEMOGLOBIN A1C; LIPID; MITIGLINIDE; VOGLIBOSE;

ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; DIET; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; EXERCISE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMODIALYSIS PATIENT; HUMAN; HYPERGLYCEMIA; INSULIN RELEASE; LOADING TEST; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE;

EID: 84876313900     PISSN: 02898020     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Esposito K, Giugliano D, Nappo F, Marfella R; Campanian Postprandial Hyperglycemia Study Group. Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus. Circulation 2004;110:214-9. (Pubitemid 38924590)
2. Monnier L, Colette C, Dunseath GJ, Owens DR. The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes. Diabetes Care 2007;30:263-9. (Pubitemid 46198328)
3. Inoue M. Tighter control of postprandial hyperglycemia with mitiglinide/voglibose fixed-dose combination in Japanese patients with type 2 diabetes mellitus. Expert Opin Pharmacother 2012;13:2257-68.
4. Ono Y, Kameda H, Cho KY. Mitiglinide/voglibose fixed-dose combination improves postprandial glycemic excursions in Japanese patients with type 2 diabetes mellitus. Expert Opin Pharmacother 2013;14:361-70.
5. Kashiwagi A, Kasuga M, Araki E, Oka Y, Hanafusa T, Ito H, et al. International clinical harmonization of glycated hemoglobin in Japan : from Japan Diabetes Society to National Glycohemoglobin Standardization Program values. J Diabetes Investig 2012;3:39-40.
6. The DECODE Study Group, on behalf of the European Diabetes Epidemiology Group. Is fasting glucose sufficient to define diabetes? Epidemiological data from 20 European studies. Diabetologia 1999;42:647-54.
7. Qiao Q, Nakagami T, Tuomilehto J, Borch-Johnsen K, Balkau B, Iwamoto Y, et al. Comparison of the fasting and the 2-h glucose criteria for diabetes in different Asian cohorts. Diabetologia 2000;43:1470-5. (Pubitemid 32734853)
8. Esposito K, Ciotola M, Carleo D, Schisano B, Sardelli L, Di Tommaso D, et al. Post-meal glucose peaks at home associate with carotid intima-media thickness in type 2 diabetes. J Clin Endocrinol Metab 2008;93:1345-50. (Pubitemid 351519731)
9. Monnier L, Lapinski H, Colette C. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients : variations with increasing levels of HbA1c. Diabetes Care 2003;26:881-5. (Pubitemid 36929359)
10. Sakuma N, Omura M, Oda E, Saito T. Converse contributions of fasting and postprandial glucose to HbA1c and glycated albumin. Diabetol Int 2011;2:162-71.
11. Dungan KM, Buse JB, Largay J, Kelly MM, Button EA, Kato S, et al. 1,5-anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes. Diabetes Care 2006;29:1214-9. (Pubitemid 44125912)
12. Diabetes Frontier 2010;21:154-8.
13. Diabetes Strategy 2011;1:105-15.
14. International Diabetes Federation. Guideline for Management of PostMeal Glucose in Diabetes. Brussels : International Diabetes Federation; 2011. p.29.
15. Ogawa S, Takeuchi K, Ito S. Acarbose lowers serum triglyceride and postprandial chylomicron levels in type 2 diabetes. Diabetes Obes Metab 2004;6:384-90. (Pubitemid 39177431)
16. Abe M, Okada K, Maruyama T, Naruyama N, Matsumoto K. Combination therapy with mitiglinide and voglibose improves glycemic control in type 2 diabetic patients on hemodialysis. Expert Opin Pharmacother 2010;11:169-76.